English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Medin, a  50-residue cleavage polypeptide of milk fat globule protein epidermal growth factor 8 (MFG-E8), has been deemed to play key roles in the pathogenesis of many cardiovascular diseases, including aortic amyloidosis, hypertension, atherosclerosis, aortic dissection, heart failure, and coronary artery disease. The interactions between medin and vascular cells, such as endothelial cells in intima, vascular smooth muscle cells in media, and fibroblasts in adventitia, are considered to be involved in the pathophysiological processes of the vascular remodelling that underlies cardiovascular diseases. Recent evidence has indicated that medin could also act as a scaffold to facilitate the depositions of other types of amyloid proteins, thereby inducing cardiovascular injuries.

Medin amyloid and cardiovascular diseases: a review of the biology and the implications for the diagnosis and treatment of cardiac amyloidosis